Arthroscopy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Arthroscopy is the foundational minimally invasive surgical platform of modern orthopedic and sports medicine practice. A small camera—the arthroscope—measuring 2.7 to 4.0 mm in diameter is inserted through a 5–10 mm portal into the joint. Saline or lactated Ringer's solution distends the joint cavity, providing visualization of articular surfaces, menisci, ligaments, tendons, and synovium. Specialized instruments (shavers, burrs, punches, suture-passers, and radiofrequency probes) are introduced through one to three additional portals for operative procedures.

Arthroscopy is applicable to virtually every synovial joint. The knee is the most commonly treated joint: procedures include partial or total meniscectomy, meniscal repair, ACL and PCL reconstruction, chondroplasty, microfracture, synovectomy, and removal of loose bodies. The shoulder ranks second: rotator cuff repair (supraspinatus, infraspinatus, subscapularis), Bankart labral repair for instability, SLAP repair, subacromial decompression, distal clavicle excision for AC joint arthritis, and biceps tenodesis are all performed entirely arthroscopically by experienced surgeons.

Hip arthroscopy addresses femoroacetabular impingement (FAI—cam or pincer morphology), labral tears, loose bodies, synovial chondromatosis, and hip dysplasia correction. Ankle arthroscopy treats osteochondral lesions of the talus, anterior ankle impingement (athlete's ankle), posterior impingement, and lateral ligament repair. Elbow and wrist arthroscopy are more specialized, addressing loose bodies, lateral epicondylitis debridement, TFCC tears, and scaphoid non-union assessment. Diagnostic arthroscopy remains the gold standard for intra-articular pathology when MRI or CT arthrogram findings are equivocal.

The breadth of arthroscopic indications spans from acute traumatic pathology to degenerative joint disease requiring targeted intervention. In the knee, the most common indication is meniscal tears—including bucket-handle tears causing mechanical locking, radial tears, and degenerative flap tears. Cartilage defects (Outerbridge grade III–IV), synovitis from inflammatory arthropathy, loose bodies causing intermittent locking and effusion, and patellofemoral syndrome with lateral retinacular tightness are all managed arthroscopically. ACL and PCL reconstruction is performed entirely through arthroscopic portals.

Shoulder arthroscopy indications include symptomatic full-thickness and high-grade partial rotator cuff tears, shoulder impingement syndrome refractory to physiotherapy and injection, anterior instability with Bankart lesion, posterior instability, SLAP lesions causing pain in overhead athletes (throwers, swimmers), biceps tendinopathy requiring tenodesis or tenotomy, and symptomatic AC joint osteoarthritis requiring distal clavicle resection.

Hip arthroscopy is indicated for femoroacetabular impingement with labral tears causing groin pain and restricted motion in athletes, particularly runners, hockey players, and ballet dancers. Ankle arthroscopy is valuable for osteochondral lesions of the talus (OLT) that fail conservative management, anterior impingement from bony spurs in soccer players and gymnasts, chronic lateral ankle instability with associated synovitis, and peroneal tendon instability. Importantly, arthroscopic debridement for established osteoarthritis provides no benefit above physiotherapy (METEOR and FIDELITY trials) and should not be performed for this indication.

Arthroscopy is appropriate when symptomatic intra-articular pathology has been confirmed clinically and on imaging, and conservative treatment has been adequately trialed. For most elective indications—meniscal tears (non-locked), rotator cuff tears in older patients, hip FAI—a minimum of 3 to 6 months of physiotherapy, activity modification, and potentially corticosteroid or hyaluronic acid injection should precede surgical referral.

Exceptions to the conservative trial requirement include: mechanically locked knee from displaced bucket-handle meniscal tear (urgent arthroscopy regardless of duration of symptoms); acute complete rotator cuff tear in young, active patients; acute traumatic Bankart lesion in high-risk athletes (early surgery substantially reduces recurrence); and locked joints from loose bodies. Patients with severe established osteoarthritis are generally not candidates for arthroscopic debridement, as evidence shows no meaningful improvement over conservative care.

Pre-operative imaging guides surgical planning. MRI is the primary modality for soft tissue evaluation—menisci, tendons, labrum, cartilage, and ligaments. CT arthrogram is preferred for bony labral lesions and cartilage assessment in the hip. Plain X-rays evaluate bone morphology, osteophytes, joint space, and calcifications. Articular cartilage status on MRI is critical for prognosis: severe diffuse cartilage loss predicts poor outcomes from isolated meniscectomy or debridement. All patients require pre-anesthetic clearance. Regional anesthesia (spinal or femoral nerve block) is increasingly used to reduce opioid requirements and facilitate same-day discharge.

Arthroscopy is used both diagnostically and therapeutically across all major joints:

• Knee arthroscopy: The most commonly performed arthroscopic procedure. Indications include: meniscal tear repair or partial meniscectomy (medial and lateral), ACL/PCL reconstruction, cartilage procedures (microfracture, MACI implantation, osteochondral autograft transplantation — OATS), synovectomy for inflammatory arthritis, loose body removal, debridement for focal chondromalacia, and plica excision. Standard portals: anteromedial and anterolateral with additional portals as required.
• Shoulder arthroscopy: Rotator cuff tear repair (single-row, double-row, and suture bridge configurations), SLAP (superior labrum anterior-posterior) repair, Bankart repair for anterior shoulder instability, acromioplasty and subacromial decompression, biceps tenodesis or tenotomy, AC joint resection for acromioclavicular arthritis, and capsular release for adhesive capsulitis. Advantages over open: less deltoid disruption, faster rehabilitation, lower infection rates.
• Hip arthroscopy: Management of femoroacetabular impingement (FAI) — osteoplasty of cam (femoral head-neck junction) or pincer (acetabular rim) lesions, labral repair or reconstruction, synovectomy, and loose body removal. Technical demanding due to deep joint location and traction requirements.
• Ankle arthroscopy: Anterior ankle impingement (synovial and bony impingement resection), osteochondral lesions of the talus (OLT — microfracture, OATS, or autologous chondrocyte implantation), posterior ankle impingement, syndesmotic stabilization, and loose body removal.
• Wrist and elbow arthroscopy: Wrist: TFCC (triangular fibrocartilage complex) repair, scaphoid fracture fixation, carpal instability assessment, loose body removal. Elbow: lateral epicondylitis release, loose body removal, ulnar nerve management, olecranon impingement.
• General technique: Small portals (5–10 mm) are created and a fluid distension medium (normal saline or lactated Ringer's) maintained at 40–60 mmHg provides joint distension and visibility. The arthroscope (typically 4 mm for large joints, 1.9–2.7 mm for small joints) provides high-definition visualization on a monitor. Powered shavers, burrs, electrocautery, and suture-passing devices allow therapeutic interventions through accessory portals.

Arthroscopy offers the core advantages of minimally invasive surgery: smaller incisions, reduced blood loss, lower infection rates, shorter hospital stay (typically same-day discharge), faster recovery, and equivalent or superior outcomes compared to open surgery for the vast majority of intra-articular procedures.

Knee meniscal outcomes depend critically on whether repair or resection is performed. Meniscal repair in appropriately selected tears (peripheral red-red zone, younger patients, concurrent ACL reconstruction) achieves 75–90% healing rates and protects against long-term osteoarthritis. Partial meniscectomy for isolated unstable tears results in 85–90% pain relief in the short term but increases osteoarthritis risk proportionally to the amount resected—underscoring the preference for repair when technically feasible.

Shoulder outcomes are similarly strong. Arthroscopic rotator cuff repair produces outcomes equivalent to open repair for all tear sizes, with faster early recovery. Bankart repair for anterior shoulder instability achieves recurrence rates of 5–10% compared to 50–80% without surgery in young athletes, with 75–85% returning to contact sports. Hip arthroscopy for FAI with labral repair demonstrates 80–85% pain relief and return to sport at 2 years, with inferior outcomes in patients with pre-existing moderate osteoarthritis. Ankle arthroscopy for OLT achieves good-to-excellent results in 80–90% of grade I–III lesions.

Arthroscopy is among the safest surgical procedures, with overall serious complication rates below 1–2%. Nevertheless, surgeons and patients must be aware of procedure-specific and general risks.

Deep vein thrombosis (DVT) occurs in 0.5–1% of knee arthroscopy cases and is more common with prolonged tourniquet use and immobility. Chemical thromboprophylaxis (low-molecular-weight heparin or aspirin) is recommended for higher-risk patients. Infection is uncommon (<0.5%) but can be devastating when it occurs, potentially requiring repeat arthroscopic washout, prolonged antibiotic therapy, or open debridement. Portal-site neuralgia from cutaneous nerve injury occurs transiently in 5–10% of cases and almost universally resolves within 3–6 months.

Fluid extravasation—accumulation of irrigation fluid in surrounding soft tissues—is generally minor but can occasionally cause compartment syndrome, a surgical emergency. Instrument breakage inside the joint requiring retrieval is rare but possible with older or fatigued instruments. Iatrogenic articular cartilage damage from instruments or the arthroscope itself (chondral scuffing) can exacerbate pre-existing lesions. Inadequate treatment or missed lesions may require repeat arthroscopy or conversion to open surgery. Hip arthroscopy carries specific risks of traction neuropraxia (pudendal, sciatic, lateral femoral cutaneous nerves) from the hip distractor required for portal placement, and fluid extravasation into the retroperitoneum in rare cases. Shoulder arthroscopy risks include axillary nerve injury and brachial plexus traction neuropraxia from the lateral decubitus or beach-chair position.

Recovery varies significantly based on the procedure performed:

• Diagnostic or simple procedures (synovectomy, loose body removal, debridement): Day surgery; weight-bearing as tolerated immediately for knee procedures. Driving at 1–2 weeks. Return to sedentary work within 1–2 weeks. Light sports at 4–6 weeks.
• Meniscal repair: 4–6 weeks non-weight-bearing or protected weight-bearing to protect the repair during vascular ingrowth. Running at 12–16 weeks; return to sport at 4–6 months pending MRI healing confirmation.
• Rotator cuff repair: Shoulder sling for 4–6 weeks. Passive range of motion only for first 6 weeks. Progressive active strengthening at 6–12 weeks. Return to overhead sport at 9–12 months. Healing confirmed on ultrasound or MRI at 3–6 months.
• FAI (hip) surgery: Crutches for 2–4 weeks; aquabike at 6 weeks; running at 12–16 weeks; return to sport at 4–6 months.
• Follow-up schedule: Standard post-operative review at 2 weeks (wound check), 6 weeks (physiotherapy progression assessment), 3 months (functional assessment), and 12 months (final outcome documentation). Re-imaging (MRI or ultrasound) at 3–6 months for repaired structures to confirm healing. Patient-reported outcomes (KOOS, IKDC, ASES, HOS) at baseline and 3, 12, and 24 months.

Arthroscopy costs vary significantly by joint, complexity, and country. Simpler procedures (partial meniscectomy, subacromial decompression) fall at the lower end of cost ranges; complex reconstructions (ACL, rotator cuff, FAI with labral repair) are at the higher end.

India: $2,000–$6,000. High-volume arthroscopic centers in tertiary hospitals across Bangalore, Mumbai, Delhi, and Chennai offer internationally trained surgeons at a fraction of Western costs. NABH and JCI-accredited hospitals available.

Thailand: $4,000–$10,000. Bangkok's international hospitals (Bumrungrad, Samitivej, Bangkok Hospital) have established orthopedic and sports medicine programs serving international patients year-round.

Turkey: $3,000–$7,000. Istanbul and Ankara offer well-equipped orthopedic centers with European-trained arthroscopic surgeons and competitive pricing.

South Korea: $4,000–$8,000. Advanced technology and highly skilled surgeons; strong reputation for orthopedic and sports medicine outcomes.

Mexico: $3,000–$7,000. Accessible for North American patients; major cities have internationally accredited facilities.

USA: $8,000–$25,000. Highly variable by procedure and facility; outpatient surgery centers substantially cheaper than hospital-based operating rooms. Insurance coverage is usually available for medically necessary procedures.

UK (Private): £4,000–£12,000. NHS provides this surgery free for eligible residents, but waiting lists may be 6–12 months for elective arthroscopy.

Australia: $5,000–$15,000. Private hospital costs partially offset by private health insurance; some waiting time in public systems.

Many joint conditions managed arthroscopically may also respond to conservative treatment, particularly for degenerative pathology:

• Physical therapy: Exercise-based rehabilitation is first-line for degenerative meniscal tears in patients over 45. The METEOR trial and KANON trial demonstrated no significant advantage of arthroscopic partial meniscectomy over sham surgery or physical therapy for degenerative medial meniscal tears in middle-aged adults. Structured physiotherapy with neuromuscular and strengthening components should precede arthroscopy for degenerative meniscal pathology.
• Intra-articular injections: Corticosteroid injections provide 4–8 weeks of pain relief for inflammatory joint conditions. Hyaluronic acid (viscosupplementation) provides modest benefit for knee osteoarthritis. Platelet-rich plasma (PRP) has emerging evidence for knee OA and partial tendon tears. These non-surgical options are appropriate adjuncts or alternatives to arthroscopy in degenerative conditions without mechanical symptoms (locking, instability).
• Extracorporeal shockwave therapy (ESWT): Effective for enthesopathies (lateral epicondylitis, plantar fasciitis, calcific tendinitis of the rotator cuff) — many of which are treated arthroscopically when conservative measures fail.
• Activity modification and lifestyle: Weight loss reduces intra-articular loading and inflammation in knee and hip OA. BMI reduction of 5 units decreases knee pain and disability significantly without any procedure.